IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Track this case

Case overview

Case Number:

2:16-md-02724

Court:

Pennsylvania Eastern

Nature of Suit:

Other Statutes: Anti-Trust

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

CYNTHIA M. RUFE

Firms

Companies

Government Agencies

State of Maryland

Sectors & Industries:

November 09, 2022
Drug Buyers, States Want To Depose Indicted Ex-Taro Exec

A group of drug purchasers and state-level enforcers accusing generic-drug manufacturers of fixing prices asked a Pennsylvania federal court on Tuesday to allow it to depose a former top executive who was indicted on criminal antitrust charges ahead of his trial.
June 07, 2022
AGs' Disgorgement Claim Axed In Drug Price-Fixing Case

The Pennsylvania federal judge overseeing sprawling price-fixing litigation against generic-drug makers on Tuesday tossed a disgorgement claim brought by state attorneys general, but kept alive their claim for injunctive relief.
May 25, 2022
Generic Distributors Slip Indirect Reseller Price-Fixing Claims

A Pennsylvania federal judge dismissed, for now, indirect generic-drug resellers' price-fixing claims levied against distributors like McKesson Corp. as a part of multidistrict litigation, ruling Wednesday that the plaintiffs failed to sufficiently allege a conspiracy.
May 20, 2022
Drugmakers Say Pa. AG Not Producing Generic-Drug Docs

Mylan and other pharmaceutical companies facing allegations of price-fixing for generic drugs told a Pennsylvania federal judge overseeing multidistrict litigation that the Pennsylvania Attorney General's Office has refused to produce key documents.
May 11, 2022
Settlements Worth $86M OK'd In Drug Price-Fixing MDL

Deals for three generic-drug companies to fork over a combined $86 million to direct purchasers and indirect resellers to settle price-fixing allegations gained preliminary approval from a Philadelphia federal judge Wednesday.
May 10, 2022
End-Payor State Claims Stick In Generic Drug Price-Fix MDL

A Pennsylvania federal court denied a dismissal bid Tuesday from drug companies in sprawling multidistrict litigation over alleged generic drug price-fixing, refusing to toss some state claims from end-payors while rejecting arguments that intervening authority should result in the claims being nixed.
April 07, 2022
Teva Appears Headed For $100M Price-Fixing Payout To AGs

After last week's $1.45 million settlement with Louisiana's attorney general, a pattern is emerging in Teva's efforts to deal its way out of sprawling price-fixing litigation that could put the generic-drug maker on the hook for about $100 million if it settles with every state enforcer.
March 16, 2022
Drug Purchasers Seek Blessing Of Sun And Taro Deals

Generic-drug buyers on Wednesday asked a Pennsylvania federal court to certify a settlement class and preliminarily approve settlements with Sun Pharma and Taro Pharmaceuticals worth a combined $85 million, the first on behalf of any private plaintiff in sprawling multidistrict litigation over alleged price-fixing of generic drugs.
March 09, 2022
Nothing 'Innocuous' In Drugmakers' Dismissal Bid, Court Told

Generic-drug buyers urged a Pennsylvania federal judge Tuesday not to consider a dismissal bid from pharmaceutical companies more recently added to multidistrict price-fixing litigation, arguing the motion was filed in violation of an agreement to tackle bellwether cases first.
November 05, 2021
2 Sun Pharma US Units To Pay $85M In Generic Drugs MDL

Two U.S. subsidiaries of Indian drugmaker Sun Pharma have agreed to shell out a combined $85 million to a proposed class of direct purchaser plaintiffs in sweeping multidistrict litigation over alleged price-fixing of generic drugs, the companies have reportedly disclosed.

← Previous
1
2
3
4
5
6
7
8
9
Next →